In the majority of cases, genomic alterations mainly comprised SVs, except for FGFR1 alterations in salivary gland carcinoma and FGFR2 alterations in cholangiocarcinoma, in which REs were most common (Figure 2). Here, FGFR2 is linked to cholangiocarcinoma.